Regeneron stock reaches all-time high following positive clinical trial results and FDA approvals

From Google: 2024-08-09 09:38:29

Regeneron stock reaches all-time high at $1115.06, with a surge of 1.52% in trading. The pharmaceutical company has seen a steady rise in stock prices following positive clinical trial results and FDA approvals. Investors are optimistic about the company’s future growth and potential profitability.



Read more at Google: Regeneron stock soars to all-time high of $1115.06 – Investing.com India